Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Trial details
- Registry ID
- NCT05416307
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)NCT05416307 | ETRA | Phase 2, Phase 3 | Recruiting | 2028-03Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |